A
Price
$149.26
Change
+$0.45 (+0.30%)
Updated
Dec 3 closing price
Capitalization
42.25B
89 days until earnings call
Intraday BUY SELL Signals
MEDP
Price
$576.49
Change
-$7.21 (-1.24%)
Updated
Dec 3 closing price
Capitalization
16.24B
74 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

A vs MEDP

Header iconA vs MEDP Comparison
Open Charts A vs MEDPBanner chart's image
Agilent Technologies
Price$149.26
Change+$0.45 (+0.30%)
Volume$2.16M
Capitalization42.25B
Medpace Holdings
Price$576.49
Change-$7.21 (-1.24%)
Volume$245.17K
Capitalization16.24B
A vs MEDP Comparison Chart in %
View a ticker or compare two or three
VS
A vs. MEDP commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Buy and MEDP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (A: $148.83 vs. MEDP: $583.57)
Brand notoriety: A and MEDP are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 27% vs. MEDP: 36%
Market capitalization -- A: $42.25B vs. MEDP: $16.24B
A [@Medical Specialties] is valued at $42.25B. MEDP’s [@Medical Specialties] market capitalization is $16.24B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $12.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 3 FA rating(s) are green whileMEDP’s FA Score has 3 green FA rating(s).

  • A’s FA Score: 3 green, 2 red.
  • MEDP’s FA Score: 3 green, 2 red.
According to our system of comparison, A is a better buy in the long-term than MEDP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 4 TA indicator(s) are bullish while MEDP’s TA Score has 3 bullish TA indicator(s).

  • A’s TA Score: 4 bullish, 4 bearish.
  • MEDP’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, A is a better buy in the short-term than MEDP.

Price Growth

A (@Medical Specialties) experienced а -5.32% price change this week, while MEDP (@Medical Specialties) price change was -4.62% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.29%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was +28.81%.

Reported Earning Dates

A is expected to report earnings on Mar 03, 2026.

MEDP is expected to report earnings on Feb 16, 2026.

Industries' Descriptions

@Medical Specialties (-0.29% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($42.2B) has a higher market cap than MEDP($16.2B). MEDP has higher P/E ratio than A: MEDP (40.29) vs A (32.66). MEDP YTD gains are higher at: 75.652 vs. A (11.479). A has higher annual earnings (EBITDA): 1.8B vs. MEDP (506M). A has more cash in the bank: 1.54B vs. MEDP (46.3M). MEDP has less debt than A: MEDP (125M) vs A (3.41B). A has higher revenues than MEDP: A (6.79B) vs MEDP (2.23B).
AMEDPA / MEDP
Capitalization42.2B16.2B260%
EBITDA1.8B506M355%
Gain YTD11.47975.65215%
P/E Ratio32.6640.2981%
Revenue6.79B2.23B304%
Total Cash1.54B46.3M3,315%
Total Debt3.41B125M2,727%
FUNDAMENTALS RATINGS
A vs MEDP: Fundamental Ratings
A
MEDP
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
87
Overvalued
PROFIT vs RISK RATING
1..100
5713
SMR RATING
1..100
4514
PRICE GROWTH RATING
1..100
1438
P/E GROWTH RATING
1..100
3315
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (20) in the Biotechnology industry is significantly better than the same rating for MEDP (87) in the Miscellaneous Commercial Services industry. This means that A’s stock grew significantly faster than MEDP’s over the last 12 months.

MEDP's Profit vs Risk Rating (13) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for A (57) in the Biotechnology industry. This means that MEDP’s stock grew somewhat faster than A’s over the last 12 months.

MEDP's SMR Rating (14) in the Miscellaneous Commercial Services industry is in the same range as A (45) in the Biotechnology industry. This means that MEDP’s stock grew similarly to A’s over the last 12 months.

A's Price Growth Rating (14) in the Biotechnology industry is in the same range as MEDP (38) in the Miscellaneous Commercial Services industry. This means that A’s stock grew similarly to MEDP’s over the last 12 months.

MEDP's P/E Growth Rating (15) in the Miscellaneous Commercial Services industry is in the same range as A (33) in the Biotechnology industry. This means that MEDP’s stock grew similarly to A’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMEDP
RSI
ODDS (%)
Bearish Trend 7 days ago
56%
Bearish Trend 7 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
61%
Bearish Trend 7 days ago
72%
Momentum
ODDS (%)
Bullish Trend 7 days ago
65%
Bullish Trend 7 days ago
74%
MACD
ODDS (%)
Bullish Trend 7 days ago
72%
Bearish Trend 7 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
64%
Bullish Trend 7 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
60%
Bullish Trend 7 days ago
76%
Advances
ODDS (%)
Bullish Trend 10 days ago
62%
Bullish Trend 11 days ago
75%
Declines
ODDS (%)
Bearish Trend 7 days ago
59%
Bearish Trend 7 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
57%
Bearish Trend 7 days ago
61%
Aroon
ODDS (%)
Bullish Trend 7 days ago
61%
Bullish Trend 7 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
A
Daily Signal:
Gain/Loss:
MEDP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
URNM56.001.24
+2.26%
Sprott Uranium Miners ETF
EMTY12.110.07
+0.57%
ProShares Decline of the Retl Store ETF
BRTR50.940.03
+0.05%
iShares Total Return Active ETF
IFED45.93N/A
N/A
ETRACS IFED Inv with the Fd TR ETN
INDH44.52-0.14
-0.30%
WisdomTree India Hedged Equity

A and

Correlation & Price change

A.I.dvisor indicates that over the last year, A has been closely correlated with MTD. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if A jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To A
1D Price
Change %
A100%
-0.85%
MTD - A
85%
Closely correlated
-1.48%
WAT - A
81%
Closely correlated
+0.20%
TMO - A
79%
Closely correlated
-0.84%
RVTY - A
79%
Closely correlated
+0.33%
DHR - A
77%
Closely correlated
+1.11%
More

MEDP and

Correlation & Price change

A.I.dvisor indicates that over the last year, MEDP has been closely correlated with IQV. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if MEDP jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEDP
1D Price
Change %
MEDP100%
-0.75%
IQV - MEDP
73%
Closely correlated
-1.23%
CRL - MEDP
49%
Loosely correlated
-0.73%
MTD - MEDP
49%
Loosely correlated
-1.48%
RVTY - MEDP
48%
Loosely correlated
+0.33%
A - MEDP
46%
Loosely correlated
-0.85%
More